A critical breakthrough in cancer study is occurring with the use of VHH fragments to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently disabled in several kinds of cancer, causing https://dirstop.com/story29805379/mini-antibodies-restore-the-p53-protein-a-new-approach-for-tumor-therapy